Pura Vida Investments’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Pura Vida Investments’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-412,500	Closed	-$2.27M	–	110
2016 Q3	$2.27M	Buy	412,500 +62,500	+18%	+$293K	0.69%	58
2016 Q2	$1.33M	Sell	350,000 -222,800	-39%	-$755K	0.57%	57
2016 Q1	$1.58M	Buy	572,800 +200,000	+54%	+$724K	0.72%	50
2015 Q4	$2.11M	Sell	372,800 -27,200	-7%	-$166K	0.89%	46
2015 Q3	$2.12M	Buy	400,000 +153,750	+62%	+$1.19M	1.21%	37
2015 Q2	$2.25M	Sell	246,250 -78,450	-24%	-$380K	1.15%	41
2015 Q1	$1.5M	Buy	324,700 +74,700	+30%	+$243K	0.77%	45
2014 Q4	$763K	Buy	+250,000	New	+$739K	0.28%	63

Other funds holding SGYP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pura Vida Investments's SGYP Position: Q4 2016 in Review

Pura Vida Investments sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016, closing a stake of 412,500 shares — an estimated $2.27M sold.

Pura Vida Investments first reported a position in SGYP in Q4 2014 and held it in 8 quarters. The position peaked at $2.27M in Q3 2016. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

Pura Vida Investments reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2016 after selling out during the quarter.
Pura Vida Investments sold 412,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $2.27M.
Pura Vida Investments first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2014 and held it in 8 quarters.
Pura Vida Investments's Synergy Pharmaceuticals, Inc Common Stock position peaked at $2.27M in Q3 2016.
156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on Pura Vida Investments's 13F filing for Q4 2016, filed 14 Feb 2017.